PROHANCE 0.5 mmol/ml, solution for injection bottle, 20 ml
Active ingredients: Gadoteridol
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROHANCE 0,5 mmol/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 20 mL
- Marketing authorisation holder
- BRACCO IMAGING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69155907CIP73378549CIP133400933785499Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GADOTÉRIDOLsolution | 279,3 mg · 1 mL de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.